News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Articles by By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry

ByBy Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

September 26th 2022

Latest Updated Articles

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry
September 26th 2022

Trending on Psychiatric Times

New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression

Suicide Risk Assessment in Patients Denying Suicidal Intent

Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: Comparing Efficacy and Tolerability

New Name, New Path for Psychiatry: The Future of the DSM